tradmap

VTAK Financials Catheter Precision, Inc.

9 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 25.9% per year over the past 5 years.
  • Operating margin has expanded, at -2581.6% in the latest year.

Financial health

  • Total debt ($3M) exceeds cash ($88000); net debt is $3M.
  • The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
-$71M -$32M $7M $0 2017 2018 2019 2020 2021 2022 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
-192579% -96243% 93% 0% 2017 2018 2019 2020 2021 2022 2023 2024 2025
GrossOperatingNet
Free cash flow (CFO − capex)
-$33M -$17M $0 2017 2018 2019 2020 2021 2022 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $32M $64M 2017 2018 2019 2020 2021 2022 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$33M $21M $75M $0 2017 2018 2019 2020 2021 2022 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $819000 -$17M 92.3% -2581.6% -$8M $3M $88000
2024 $420000 -$17M 90.0% -2676.9% -$9M $3M
2023 $442000 -$71M 93.2% -17674.0% -$21M $4M
2022 $14000 -$27M -1050.0% -192578.6% -$23M $16M
2021 $22000 -$25M -6990.9% -133027.3% -$28M $15M
2020 $259000 -$36M -738.6% -13668.3% -$28M $24M
2019 $7M -$57M -22.9% -801.9% -$33M $558000 $15M
2018 $6M -$31M 32.8% -498.0% -$19M $850000 $64M
2017 $6M -$18M 29.0% -302.6% -$6M $8M

Valuation over time

How the market has priced VTAK against its own fundamentals since 2023-08 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 51.9 103.9 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S

Frequently asked questions

Is VTAK growing its revenue and profit?

Over the past 5 years, Catheter Precision, Inc.'s revenue has grown 25.9% per year. These are computed facts, not advice.

How much debt does VTAK have?

As of FY2025, Catheter Precision, Inc. reported $3M of total debt against $88000 of cash.

What is VTAK's profit margin?

In FY2025, gross margin was 92.3%, operating margin -2581.6%, and net margin -2098.0%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.